Products

  1. Home
  2. Products
  3. Bone & Mineral Metabolism
  4. IDK® anti-htTG IgA ELISA

IDK® anti-htTG IgA ELISA

Item #: KR9399 Categories: ,

$372.00

Available with Lead Time!

Method: ELISA
Sample Type (Matrix): Serum, Plasma
Sample Volume: 10 µl
Species: Human
Incubation time: 2h 15m
Size: 96 wells
Regulatory Status: For research use only in the U.S.
Kit Manual: Download

The IDK® anti-htTG IgA ELISA is intended for the determination of human anti-tissue transglutaminase IgA antibodies in serum and plasma.

For research use only. Not for use in diagnostic procedures.

For Laboratory Professional Use Only.

This is the RUO version of Immundiagnostik part number K 9399.

Test Principle of the IDK® anti-htTG IgA ELISA

The IDK® anti-htTG IgA ELISA is a sandwich assay for the quantitative determination of anti-tissue transglutaminase antibodies (IgA anti-htTG).

The wells of the microtiter plate are coated with the antigen. In the first incubation step, the anti-htTG IgA antibodies are bound to the coated antigen. To remove all unbound substances, a washing step is carried out.

In a further incubation step, a peroxidase-labeled antibody is added. After another washing step to remove all unbound substances, the solid phase is incubated with the peroxidase substrate, tetramethylbenzidine (TMB). Finally, an acidic stop solution is added to terminate the enzymatic reaction, whereby the color changes from blue to yellow. The intensity of the yellow color is directly proportional to the IgA anti-tissue-transglutaminase antibody concentration.

A dose-response curve of the absorbance unit (optical density, OD at 450 nm) vs. concentration is generated using the values obtained from the standards. The presence of IgA anti-tissue transglutaminase antibodies in the samples are determined directly from this curve.

 

Additional information

Weight 35.5 oz
Dimensions 6.5 × 10 × 4.5 in
Social media & sharing icons powered by UltimatelySocial

Become an IDK Insider!

Join our mailing list to receive the latest news and updates from Immundiagnostik, Inc.

 
 
 
 

You have Successfully Subscribed!